Stay updated on Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.

Latest updates to the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe Study Record History now lists revision v3.6.6, with v3.6.5 removed from the history. This indicates an update to the page's revision history and versioning metadata.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe record history now shows a new revision version v3.6.5, replacing the previous v3.6.4. This reflects a system/UI update to the page rather than a change to the study content.SummaryDifference0.1%

- Check51 days agoChange DetectedNew revision entry added: Revision: v3.6.4, and Revision: v3.6.3 removed from the record history. This update changes only the version history on the page and does not affect trial data or content.SummaryDifference0.1%

- Check72 days agoChange DetectedThe record history shows the site revision updated from v3.6.2 to v3.6.3, indicating a minor interface update.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry (v3.6.2) was added to the record history, and the previous revision (v3.6.0) was removed. This update reflects a maintenance change to the page's version history rather than a modification to the study content.SummaryDifference0.1%

- Check94 days agoChange DetectedNew quick-access links 'Check who can join' and 'Find Contact Information' appear on the record history page to facilitate access to eligibility details and contact information for the study. The revision history now shows version 3.6.0 and removes the previous 3.5.5 entry, indicating an updated record.SummaryDifference0.6%

Stay in the know with updates to Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.